Programmdetails

Novel and conventional biomarkers complementing risk scores in patients with acute decompensated heart failure

Patients with scheduled heart valve interventions are at very high risk for acute heart failure during prolonged waiting time

Zusammenhang von Body Mass Index und Mortalität in kardiogenem Schock unterschiedlicher Ätiologie

Early IABP use in absence of cardiogenic shock in high risk protected PCI reduces infarction size and leads to more complete revascularization in comparison to rescue IAPB use

Katecholamine, stattgefundene Reanimation und Sepsis beeinflussen das Outcome nach ECLS-Implantation bei akuter Herzinsuffizienz

Right ventricular dysfunction for prediction of long-term recovery in newly diagnosed heart failure with reduced ejection fraction

Non-invasive bioimpedance analysis predicts NT-proBNP changes during hospitalization in a cohort of acutely decompensated heart failure patients

Pharmacological inhibition of GRK5 improves cardiac function in experimental Takotsubo syndrome